Global Induced Pluripotent Stem Cells Market Size study, by Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Others), , by Application (Drug Development and Discovery, Regenerative Medicine, Toxicology Studies, Others), by End-Use (Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, Hospitals & Clinics) and Regional Forecasts 2021-2027
Global Induced Pluripotent Stem Cells Market is valued approximately USD 0.95 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 8.0 % over the forecast period 2021-2027. When adult somatic cells have been genetically reprogrammed to an embryonic stem (ES) cell-like state by the forced expression of genes and proteins necessary for preserving the distinguishing features of ES cells, results in Induced Pluripotent stem (iPS) cells. iPS cells have extensive applications and have potential in drug development and discovery. As stated by National Center for Biotechnology Information, iPSC based regenerative treatment is an unique way to improve the function of deteriorated organs due to ageing such as genetic predisposition, injuries, age related muscular degeneration and chemotherapies. The increasing awareness about iPSC will drive the market. According to National Center for Biotechnology Information, iPSCs have grown popularity as more dependable in vitro human disease models for faster drug development and tailored precision medicine. National Institute of Neurological Disorders and stroke estimated the total fundings Stem Cell Research for $1626 million in financial year 2019. However, high storage cost impedes the growth of the market over the forecast period of 2021-2027. Also, with the increasing prevalence of Chronic diseases, the adoption & demand for Induced Pluripotent Stem Cells is likely to increase the market growth during the forecast period.
The regional analysis of global Induced Pluripotent Stem Cells market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the favorable government initiatives and availability of advanced research facilities. Whereas, Europe is also anticipated to exhibit highest growth rate over the forecast period 2021-2027. Factors such as improving healthcare infrastructure would create lucrative growth prospects for the Induced Pluripotent Stem Cells market across Asia-Pacific region.
Major market player included in this report are:
Lonza
Axol Biosciences Ltd.
Evitec
Hitachi Ltd.
Merck KGaA
REPROCELL Inc.
Fate Therapeutics
Thermo Fisher Scientific, Inc.
StemCellDactory III
Applied StemCell Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Derived Cell Type:
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others
By Application:
Drug development and Discovery
Regenerative Medicine
Toxicology Studies
Others
By End-Use:
Research & Academic Institutes
Biotechnology & Pharmaceuticals Companies
Hospitals & Clinics
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027
Target Audience of the Global Induced Pluripotent Stem Cells Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The regional analysis of global Induced Pluripotent Stem Cells market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the favorable government initiatives and availability of advanced research facilities. Whereas, Europe is also anticipated to exhibit highest growth rate over the forecast period 2021-2027. Factors such as improving healthcare infrastructure would create lucrative growth prospects for the Induced Pluripotent Stem Cells market across Asia-Pacific region.
Major market player included in this report are:
Lonza
Axol Biosciences Ltd.
Evitec
Hitachi Ltd.
Merck KGaA
REPROCELL Inc.
Fate Therapeutics
Thermo Fisher Scientific, Inc.
StemCellDactory III
Applied StemCell Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Derived Cell Type:
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others
By Application:
Drug development and Discovery
Regenerative Medicine
Toxicology Studies
Others
By End-Use:
Research & Academic Institutes
Biotechnology & Pharmaceuticals Companies
Hospitals & Clinics
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027
Target Audience of the Global Induced Pluripotent Stem Cells Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Induced Pluripotent Stem Cells Market, by Region, 2019-2027 (USD Billion)
1.2.2. Induced Pluripotent Stem Cells Market, by Derived Cell Type, 2019-2027 (USD Billion)
1.2.3. Induced Pluripotent Stem Cells Market, by Application, 2019-2027 (USD Billion)
1.2.4. Induced Pluripotent Stem Cells Market, by End-Use, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET DYNAMICS
3.1. Induced Pluripotent Stem Cells Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Widespread Applications of iPSC
3.1.1.2. Increasing awareness about iPSC
3.1.2. Market Challenges
3.1.2.1. High Storage Costs
3.1.3. Market Opportunities
3.1.3.1. Increasing prevalence of Chronic Diseases
CHAPTER 4. GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET, BY DERIVED CELL TYPE
5.1. Market Snapshot
5.2. Global Induced Pluripotent Stem Cells Market by Derived Cell Type, Performance - Potential Analysis
5.3. Global Induced Pluripotent Stem Cells Market Estimates & Forecasts by Derived Cell Type 2018-2027 (USD Billion)
5.4. Induced Pluripotent Stem Cells Market, Sub Segment Analysis
5.4.1. Hepatocytes
5.4.2. Fibroblasts
5.4.3. Keratinocytes
5.4.4. Amniotic Cells
5.4.5. Others
CHAPTER 6. GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Induced Pluripotent Stem Cells Market by Application, Performance - Potential Analysis
6.3. Global Induced Pluripotent Stem Cells Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
6.4. Induced Pluripotent Stem Cells Market, Sub Segment Analysis
6.4.1. Drug Development & Discovery
6.4.2. Regenerative Medicine
6.4.3. Toxicology Studies
6.4.4. Others
CHAPTER 7. GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET, BY END-USE
7.1. Market Snapshot
7.2. Global Induced Pluripotent Stem Cells Market by End-Use, Performance - Potential Analysis
7.3. Global Induced Pluripotent Stem Cells Market Estimates & Forecasts by End-Use 2018-2027 (USD Billion)
7.4. Induced Pluripotent Stem Cells Market, Sub Segment Analysis
7.4.1. Research & Academic Institutes
7.4.2. Biotechnology & Pharmaceuticals Companies
7.4.3. Hospitals & Clinics
CHAPTER 8. GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET, REGIONAL ANALYSIS
8.1. Induced Pluripotent Stem Cells Market, Regional Market Snapshot
8.2. North America Induced Pluripotent Stem Cells Market
8.2.1. U.S. Induced Pluripotent Stem Cells Market
8.2.1.1. Derived Cell Type breakdown estimates & forecasts, 2018-2027
8.2.1.2. Application breakdown estimates & forecasts, 2018-2027
8.2.1.3. End-Use breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Induced Pluripotent Stem Cells Market
8.3. Europe Induced Pluripotent Stem Cells Market Snapshot
8.3.1. U.K. Induced Pluripotent Stem Cells Market
8.3.2. Germany Induced Pluripotent Stem Cells Market
8.3.3. France Induced Pluripotent Stem Cells Market
8.3.4. Spain Induced Pluripotent Stem Cells Market
8.3.5. Italy Induced Pluripotent Stem Cells Market
8.3.6. Rest of Europe Induced Pluripotent Stem Cells Market
8.4. Asia-Pacific Induced Pluripotent Stem Cells Market Snapshot
8.4.1. China Induced Pluripotent Stem Cells Market
8.4.2. India Induced Pluripotent Stem Cells Market
8.4.3. Japan Induced Pluripotent Stem Cells Market
8.4.4. Australia Induced Pluripotent Stem Cells Market
8.4.5. South Korea Induced Pluripotent Stem Cells Market
8.4.6. Rest of Asia Pacific Induced Pluripotent Stem Cells Market
8.5. Latin America Induced Pluripotent Stem Cells Market Snapshot
8.5.1. Brazil Induced Pluripotent Stem Cells Market
8.5.2. Mexico Induced Pluripotent Stem Cells Market
8.6. Rest of The World Induced Pluripotent Stem Cells Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Lonza
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Axol Biosciences Ltd.
9.2.3. Evitec
9.2.4. Hitachi Ltd.
9.2.5. Merck KGaA
9.2.6. REPROCELL Inc.
9.2.7. Fate Therapeutics
9.2.8. Thermo Fisher Scientific, Inc.
9.2.9. StemCellDactory III
9.2.10. Applied StemCell Inc.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Induced Pluripotent Stem Cells Market, by Region, 2019-2027 (USD Billion)
1.2.2. Induced Pluripotent Stem Cells Market, by Derived Cell Type, 2019-2027 (USD Billion)
1.2.3. Induced Pluripotent Stem Cells Market, by Application, 2019-2027 (USD Billion)
1.2.4. Induced Pluripotent Stem Cells Market, by End-Use, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET DYNAMICS
3.1. Induced Pluripotent Stem Cells Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Widespread Applications of iPSC
3.1.1.2. Increasing awareness about iPSC
3.1.2. Market Challenges
3.1.2.1. High Storage Costs
3.1.3. Market Opportunities
3.1.3.1. Increasing prevalence of Chronic Diseases
CHAPTER 4. GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET, BY DERIVED CELL TYPE
5.1. Market Snapshot
5.2. Global Induced Pluripotent Stem Cells Market by Derived Cell Type, Performance - Potential Analysis
5.3. Global Induced Pluripotent Stem Cells Market Estimates & Forecasts by Derived Cell Type 2018-2027 (USD Billion)
5.4. Induced Pluripotent Stem Cells Market, Sub Segment Analysis
5.4.1. Hepatocytes
5.4.2. Fibroblasts
5.4.3. Keratinocytes
5.4.4. Amniotic Cells
5.4.5. Others
CHAPTER 6. GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Induced Pluripotent Stem Cells Market by Application, Performance - Potential Analysis
6.3. Global Induced Pluripotent Stem Cells Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
6.4. Induced Pluripotent Stem Cells Market, Sub Segment Analysis
6.4.1. Drug Development & Discovery
6.4.2. Regenerative Medicine
6.4.3. Toxicology Studies
6.4.4. Others
CHAPTER 7. GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET, BY END-USE
7.1. Market Snapshot
7.2. Global Induced Pluripotent Stem Cells Market by End-Use, Performance - Potential Analysis
7.3. Global Induced Pluripotent Stem Cells Market Estimates & Forecasts by End-Use 2018-2027 (USD Billion)
7.4. Induced Pluripotent Stem Cells Market, Sub Segment Analysis
7.4.1. Research & Academic Institutes
7.4.2. Biotechnology & Pharmaceuticals Companies
7.4.3. Hospitals & Clinics
CHAPTER 8. GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET, REGIONAL ANALYSIS
8.1. Induced Pluripotent Stem Cells Market, Regional Market Snapshot
8.2. North America Induced Pluripotent Stem Cells Market
8.2.1. U.S. Induced Pluripotent Stem Cells Market
8.2.1.1. Derived Cell Type breakdown estimates & forecasts, 2018-2027
8.2.1.2. Application breakdown estimates & forecasts, 2018-2027
8.2.1.3. End-Use breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Induced Pluripotent Stem Cells Market
8.3. Europe Induced Pluripotent Stem Cells Market Snapshot
8.3.1. U.K. Induced Pluripotent Stem Cells Market
8.3.2. Germany Induced Pluripotent Stem Cells Market
8.3.3. France Induced Pluripotent Stem Cells Market
8.3.4. Spain Induced Pluripotent Stem Cells Market
8.3.5. Italy Induced Pluripotent Stem Cells Market
8.3.6. Rest of Europe Induced Pluripotent Stem Cells Market
8.4. Asia-Pacific Induced Pluripotent Stem Cells Market Snapshot
8.4.1. China Induced Pluripotent Stem Cells Market
8.4.2. India Induced Pluripotent Stem Cells Market
8.4.3. Japan Induced Pluripotent Stem Cells Market
8.4.4. Australia Induced Pluripotent Stem Cells Market
8.4.5. South Korea Induced Pluripotent Stem Cells Market
8.4.6. Rest of Asia Pacific Induced Pluripotent Stem Cells Market
8.5. Latin America Induced Pluripotent Stem Cells Market Snapshot
8.5.1. Brazil Induced Pluripotent Stem Cells Market
8.5.2. Mexico Induced Pluripotent Stem Cells Market
8.6. Rest of The World Induced Pluripotent Stem Cells Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Lonza
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Axol Biosciences Ltd.
9.2.3. Evitec
9.2.4. Hitachi Ltd.
9.2.5. Merck KGaA
9.2.6. REPROCELL Inc.
9.2.7. Fate Therapeutics
9.2.8. Thermo Fisher Scientific, Inc.
9.2.9. StemCellDactory III
9.2.10. Applied StemCell Inc.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Induced Pluripotent Stem Cells market, report scope
TABLE 2. Global Induced Pluripotent Stem Cells market estimates & forecasts by Region 2018-2027 (USD Billion)
TABLE 3. Global Induced Pluripotent Stem Cells market estimates & forecasts by Derived Cell Type 2018-2027 (USD Billion)
TABLE 4. Global Induced Pluripotent Stem Cells market estimates & forecasts by Application 2018-2027 (USD Billion)
TABLE 5. Global Induced Pluripotent Stem Cells market estimates & forecasts by End-Use 2018-2027 (USD Billion)
TABLE 6. Global Induced Pluripotent Stem Cells market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Induced Pluripotent Stem Cells market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Induced Pluripotent Stem Cells market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Induced Pluripotent Stem Cells market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Induced Pluripotent Stem Cells market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Induced Pluripotent Stem Cells market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Induced Pluripotent Stem Cells market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Induced Pluripotent Stem Cells market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Induced Pluripotent Stem Cells market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Induced Pluripotent Stem Cells market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. U.S. Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. U.S. Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 18. U.S. Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 19. Canada Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Canada Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 21. Canada Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 22. UK Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. UK Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. UK Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. Germany Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 26. Germany Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. Germany Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. RoE Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 29. RoE Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. RoE Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. China Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 32. China Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. China Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. India Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 35. India Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. India Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. Japan Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 38. Japan Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Japan Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. RoAPAC Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 41. RoAPAC Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. RoAPAC Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Brazil Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 44. Brazil Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. Brazil Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. Mexico Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 47. Mexico Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. Mexico Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. RoLA Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 50. RoLA Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. RoLA Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. Row Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 53. Row Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Row Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Induced Pluripotent Stem Cells market
TABLE 56. List of primary sources, used in the study of global Induced Pluripotent Stem Cells market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
TABLE 1. Global Induced Pluripotent Stem Cells market, report scope
TABLE 2. Global Induced Pluripotent Stem Cells market estimates & forecasts by Region 2018-2027 (USD Billion)
TABLE 3. Global Induced Pluripotent Stem Cells market estimates & forecasts by Derived Cell Type 2018-2027 (USD Billion)
TABLE 4. Global Induced Pluripotent Stem Cells market estimates & forecasts by Application 2018-2027 (USD Billion)
TABLE 5. Global Induced Pluripotent Stem Cells market estimates & forecasts by End-Use 2018-2027 (USD Billion)
TABLE 6. Global Induced Pluripotent Stem Cells market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Induced Pluripotent Stem Cells market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Induced Pluripotent Stem Cells market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Induced Pluripotent Stem Cells market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Induced Pluripotent Stem Cells market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Induced Pluripotent Stem Cells market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Induced Pluripotent Stem Cells market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Induced Pluripotent Stem Cells market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Induced Pluripotent Stem Cells market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Induced Pluripotent Stem Cells market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. U.S. Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. U.S. Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 18. U.S. Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 19. Canada Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Canada Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 21. Canada Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 22. UK Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. UK Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. UK Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. Germany Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 26. Germany Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. Germany Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. RoE Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 29. RoE Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. RoE Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. China Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 32. China Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. China Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. India Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 35. India Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. India Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. Japan Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 38. Japan Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Japan Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. RoAPAC Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 41. RoAPAC Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. RoAPAC Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Brazil Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 44. Brazil Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. Brazil Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. Mexico Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 47. Mexico Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. Mexico Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. RoLA Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 50. RoLA Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. RoLA Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. Row Induced Pluripotent Stem Cells market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 53. Row Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Row Induced Pluripotent Stem Cells market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Induced Pluripotent Stem Cells market
TABLE 56. List of primary sources, used in the study of global Induced Pluripotent Stem Cells market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
LIST OF FIGURES
FIG 1. Global Induced Pluripotent Stem Cells market, research methodology
FIG 2. Global Induced Pluripotent Stem Cells market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Induced Pluripotent Stem Cells market, key trends 2020
FIG 5. Global Induced Pluripotent Stem Cells market, growth prospects 2021-2027
FIG 6. Global Induced Pluripotent Stem Cells market, porters 5 force model
FIG 7. Global Induced Pluripotent Stem Cells market, pest analysis
FIG 8. Global Induced Pluripotent Stem Cells market, value chain analysis
FIG 9. Global Induced Pluripotent Stem Cells market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Induced Pluripotent Stem Cells market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Induced Pluripotent Stem Cells market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Induced Pluripotent Stem Cells market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Induced Pluripotent Stem Cells market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Induced Pluripotent Stem Cells market, regional snapshot 2018 & 2027
FIG 15. North America Induced Pluripotent Stem Cells market 2018 & 2027 (USD Billion)
FIG 16. Europe Induced Pluripotent Stem Cells market 2018 & 2027 (USD Billion)
FIG 17. Asia pacific Induced Pluripotent Stem Cells market 2018 & 2027 (USD Billion)
FIG 18. Latin America Induced Pluripotent Stem Cells market 2018 & 2027 (USD Billion)
FIG 19. Global Induced Pluripotent Stem Cells market, company market share analysis (2020)
FIG 1. Global Induced Pluripotent Stem Cells market, research methodology
FIG 2. Global Induced Pluripotent Stem Cells market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Induced Pluripotent Stem Cells market, key trends 2020
FIG 5. Global Induced Pluripotent Stem Cells market, growth prospects 2021-2027
FIG 6. Global Induced Pluripotent Stem Cells market, porters 5 force model
FIG 7. Global Induced Pluripotent Stem Cells market, pest analysis
FIG 8. Global Induced Pluripotent Stem Cells market, value chain analysis
FIG 9. Global Induced Pluripotent Stem Cells market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Induced Pluripotent Stem Cells market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Induced Pluripotent Stem Cells market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Induced Pluripotent Stem Cells market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Induced Pluripotent Stem Cells market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Induced Pluripotent Stem Cells market, regional snapshot 2018 & 2027
FIG 15. North America Induced Pluripotent Stem Cells market 2018 & 2027 (USD Billion)
FIG 16. Europe Induced Pluripotent Stem Cells market 2018 & 2027 (USD Billion)
FIG 17. Asia pacific Induced Pluripotent Stem Cells market 2018 & 2027 (USD Billion)
FIG 18. Latin America Induced Pluripotent Stem Cells market 2018 & 2027 (USD Billion)
FIG 19. Global Induced Pluripotent Stem Cells market, company market share analysis (2020)
